CEVA, Inc.
NASDAQ:CEVASemiconductors
+$3.40 today
- Market cap
- $718.60M
- Beta
- 2.01
- P/E (TTM)
- -113.6
- EPS (TTM)
- -$0.43
Volume 0.31M
Average 0.76M
CEVA Interest Expense
Cost of servicing the company's debt during the period.
CEVA, Inc.NASDAQ: CEVA
Interest Expense · Q1 FY2026 · quarter ended Mar 2026
Interest expense remains negative
Q1 FY2026 interest expense was $0, compared with $0 a year earlier. Trailing-twelve-month interest expense was $0.
Context
- Interest expense amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Interest expense increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly interest expense holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Expense history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Interest Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | -100.0% |
| FY2022 | 2022-12-31 | 397K | -5.5% |
| FY2021 | 2021-12-31 | 420K | — |
Interest Expense vs competitors
How CEVA compares with its peers on the latest reported figures
- CEVA's LTM Mar 2026 interest expense of $0 is the 4th highest of the 5 companies compared; the peer median is $20.45M.
- Interest expense amounts to 0.0% of revenue for CEVA, versus a peer median of 0.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $38.5M | -51.9% | +2.2% | 1.1% | |
| LTM Jul 2026 | $31.9M | -34.5% | +37.3% | 2.7% | |
| LTM Sep 2026 | $9M | +20.0% | -25.0% | 0.8% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Jul 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CEVA) | $20.45M | -34.5% | +2.2% | 0.9% | |
Competitors are the stored peer set for CEVA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 113.83M | 120.58M | 97.42M | 106.94M | 109.6M |
| Cost of Revenue | 10.38M | 15.13M | 11.65M | 12.77M | 14.16M |
| Gross Profit | 103.45M | 105.45M | 85.77M | 94.17M | 95.44M |
| Gross Margin | 90.9% | 87.5% | 88.0% | 88.1% | 87.1% |
| Research & Development | 69.09M | 70.32M | 72.69M | 71.62M | 74.83M |
| Selling, General & Admin | 25.02M | 25.66M | 25.96M | 29.5M | 31.36M |
| Operating Expenses | 96.41M | 101.56M | 99.24M | 101.72M | 106.79M |
| Depreciation & Amortization | 6.99M | 7.56M | 4.88M | 4.14M | 4.14M |
| EBITDA | 16.63M | 12.16M | (3.32M) | 1.38M | (554K) |
| EBITDA Margin | 14.6% | 10.1% | -3.4% | 1.3% | -0.5% |
| Operating Income | 7.04M | 3.9M | (13.47M) | (7.55M) | (11.35M) |
| Operating Margin | 6.2% | 3.2% | -13.8% | -7.1% | -10.4% |
| Interest Income | 1.87M | 3.19M | 4.49M | 5.88M | 6.91M |
| Interest Expense | 420K | 397K | 0 | 0 | 0 |
| Other Income / Expenses | 2.18M | 301K | 5.26M | 4.79M | 6.66M |
| Income Before Tax | 9.22M | 4.2M | (8.21M) | (2.76M) | (4.69M) |
| Pre-Tax Margin | 8.1% | 3.5% | -8.4% | -2.6% | -4.3% |
| Income Tax Expense | 6.82M | 18.08M | 10.23M | 6.03M | 5.95M |
| Net Income | 396K | (23.18M) | (11.88M) | (8.79M) | (10.64M) |
| Net Margin | 0.3% | -19.2% | -12.2% | -8.2% | -9.7% |
| EPS (Basic) | 0.02 | (1.00) | (0.51) | (0.37) | (0.44) |
| EPS (Diluted) | 0.02 | (1.00) | (0.51) | (0.37) | (0.44) |
| Weighted Avg Shares | 22.82M | 23.17M | 23.48M | 23.61M | 24.3M |
| Weighted Avg Shares (Diluted) | 23.25M | 23.17M | 23.48M | 23.61M | 24.3M |
CEVA, Inc.
NASDAQ:CEVA
Intrinsic Alpha fair value
Locked
Current Price
$25.19
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.